Applied Therapeutics, Inc. (APLT)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 03:38PM EDT. Market open.
| Previous Close | 7.70 |
| Open | 7.74 |
| Bid | 8.03 x 400 |
| Ask | 8.13 x 100 |
| Day's Range | 7.71 - 8.35 |
| 52 Week Range | 1.79 - 9.39 |
| Volume | |
| Avg. Volume | 2,380,314 |
| Market Cap | 926.233M |
| Beta (5Y Monthly) | 2.05 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.43 |
| Earnings Date | Nov 07, 2024 - Nov 11, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.80 |
ZacksIs Applied Therapeutics (APLT) Stock Outpacing Its Medical Peers This Year?
Here is how Applied Therapeutics Inc. (APLT) and Cardinal Health (CAH) have performed compared to their sector so far this year.
ZacksAll You Need to Know About Applied Therapeutics (APLT) Rating Upgrade to Buy
Applied Therapeutics (APLT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ZacksAPLT Stock Soars 69% on Positive Update on Galactosemia Drug NDA
Applied Therapeutics stock surges 69% as the FDA says that no advisory committee meeting is required to discuss the govorestat NDA for classic galactosemia.
© 2024 Yahoo. All rights reserved.